6505--Revlimid, Pomalyst, Camzyos Specialty Pharmaceuticals
Award Notice Posted
- Solicitation number
- 36C25226N0198
- Agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to Bristol-Myers Squibb Company
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79724D010136C25226N0198 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 issued an Award Notice on January 6, 2026, for a specialty pharmaceutical contract awarded to Bristol-Myers Squibb Company on December 31, 2025. The contract, valued at $848,445.00, covers the supply of three critical medications—Revlimid (lenalidomide), Pomalyst (pomalidomide), and Camzyos (mavacamten)—to support treatment of multiple myeloma, certain lymphomas, and obstructive hypertrophic cardiomyopathy for approximately 14 patients at the William S. Middleton Memorial VA Medical Center. The procurement was structured as a sole-source acquisition through an existing VA National Acquisition Center Federal Supply Schedule contract due to Bristol-Myers Squibb's proprietary Risk Evaluation and Mitigation Strategy (REMS) programs that restrict drug distribution to a closed network of specialty pharmacies, including CoverMyMeds/McKesson Specialty Pharmacy. The contracting officer for this award is Stacy Massey, based at the VA's Network Contracting Office in Milwaukee, Wisconsin.
Notice text
Awarded contract 36F79724D010136C25226N0198 to Bristol-Myers Squibb Company for 848445.00 on 2025-12-31.
Files
| File | Type | Posted |
|---|---|---|
| Limiting_Sources_Justification_OVER_SAT Redacted.pdf | ||
| 36F79724D0101 36C25226N0198_1.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity